| Meta-analyses of colorectal cancer risk factors CM Johnson, C Wei, JE Ensor, DJ Smolenski, CI Amos, B Levin, DA Berry Cancer causes & control 24, 1207-1222, 2013 | 1097 | 2013 |
| Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis M Naguib, AF Kopman, JE Ensor British journal of anaesthesia 98 (3), 302-316, 2007 | 413 | 2007 |
| Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells WH Mondesire, W Jian, H Zhang, J Ensor, MC Hung, GB Mills, ... Clinical cancer research 10 (20), 7031-7042, 2004 | 405 | 2004 |
| Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H) J Goldstein, B Tran, J Ensor, P Gibbs, HL Wong, SF Wong, E Vilar, J Tie, ... Annals of Oncology 25 (5), 1032-1038, 2014 | 319 | 2014 |
| MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers R Luthra, RR Singh, MG Luthra, YX Li, C Hannah, AM Romans, ... Oncogene 27 (52), 6667-6678, 2008 | 319 | 2008 |
| Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: a randomized clinical trial SF Shaitelman, PJ Schlembach, I Arzu, M Ballo, ES Bloom, D Buchholz, ... JAMA oncology 1 (7), 931-941, 2015 | 312 | 2015 |
| Survival differences among women with de novo stage IV and relapsed breast cancer S Dawood, K Broglio, J Ensor, GN Hortobagyi, SH Giordano Annals of oncology 21 (11), 2169-2174, 2010 | 287 | 2010 |
| An injectable nanoparticle generator enhances delivery of cancer therapeutics R Xu, G Zhang, J Mai, X Deng, V Segura-Ibarra, S Wu, J Shen, H Liu, ... Nature biotechnology 34 (4), 414-418, 2016 | 283 | 2016 |
| Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy PK Morrow, GM Wulf, J Ensor, DJ Booser, JA Moore, PR Flores, Y Xiong, ... Journal of Clinical Oncology 29 (23), 3126-3132, 2011 | 263 | 2011 |
| Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer X He, FJ Esteva, J Ensor, GN Hortobagyi, MH Lee, SCJ Yeung Annals of oncology 23 (7), 1771-1780, 2012 | 249 | 2012 |
| 14-3-3ζ overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival CL Neal, J Yao, W Yang, X Zhou, NT Nguyen, J Lu, CG Danes, H Guo, ... Cancer research 69 (8), 3425-3432, 2009 | 230 | 2009 |
| Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma JSL Earle, R Luthra, A Romans, R Abraham, J Ensor, H Yao, SR Hamilton The Journal of Molecular Diagnostics 12 (4), 433-440, 2010 | 215 | 2010 |
| Predictive performance of three multivariate difficult tracheal intubation models: a double-blind, case-controlled study M Naguib, FL Scamman, C O'Sullivan, J Aker, AF Ross, S Kosmach, ... Anesthesia & Analgesia 102 (3), 818-824, 2006 | 214 | 2006 |
| 14-3-3ζ turns TGF-β’s function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2 J Xu, S Acharya, O Sahin, Q Zhang, Y Saito, J Yao, H Wang, P Li, L Zhang, ... Cancer cell 27 (2), 177-192, 2015 | 195 | 2015 |
| Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia LS Elting, C Lu, CP Escalante, SH Giordano, JC Trent, C Cooksley, ... Journal of clinical oncology 26 (4), 606-611, 2008 | 191 | 2008 |
| Practical guidelines for repair of partial mastectomy defects using the breast reduction technique in patients undergoing breast conservation therapy SJ Kronowitz, KK Hunt, HM Kuerer, EA Strom, TA Buchholz, JE Ensor, ... Plastic and Reconstructive Surgery 120 (7), 1755-1768, 2007 | 177 | 2007 |
| A pilot study evaluating predictors of postoperative outcomes after major abdominal surgery: physiological capacity compared with the ASA physical status classification system CE Hightower, BJ Riedel, BW Feig, GS Morris, JE Ensor Jr, VD Woodruff, ... British journal of anaesthesia 104 (4), 465-471, 2010 | 168 | 2010 |
| Association of activated transcription factor nuclear factor κB with chemoradiation resistance and poor outcome in esophageal carcinoma JG Izzo, U Malhotra, TT Wu, J Ensor, R Luthra, JH Lee, SG Swisher, ... Journal of Clinical Oncology 24 (5), 748-754, 2006 | 168 | 2006 |
| Osimertinib-induced cardiotoxicity: a retrospective review of the FDA Adverse Events Reporting System (FAERS) K Anand, J Ensor, B Trachtenberg, EH Bernicker Cardio Oncology 1 (2), 172-178, 2019 | 143 | 2019 |
| Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies MJ Wallace, R Murthy, PP Kamat, T Moore, SH Rao, J Ensor, S Gupta, ... Journal of Vascular and Interventional Radiology 18 (12), 1500-1507, 2007 | 139 | 2007 |
Francisco J. EstevaChief, Breast Medical Oncology, Northwell Health Cancer Institute at Lenox Hill HospitalVerified email at northwell.edu